Pomegranate Punica granatum L.
Also called: pomegranate extract, pomegranate juice, Punica granatum
Pomegranate is a small fruit-bearing tree now cultivated widely. Juice from the seed arils and fruit extracts are used as foods and dietary supplements; many studies used juice rather than supplements.
- Category
- Botanical
- Part used
- Fruit juice (from the arils), fruit extracts and seed oil
- Strongest evidence
- B Some positive trials
- Native range
- Native from northeastern Türkiye to western and northern Pakistan (POWO: "NE. Türkiye to W. & N. Pakistan")
- Reviewed
- 2026-10-29
Class 1 Well studied in people. A 2025 meta-analysis (BMC Nutr) included 34 placebo-controlled RCTs (1,500 adults) of pomegranate products; trials with complex interventions were excluded. [9]
Fact-checked 2026-10-29 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
BHeart and blood vessels2 topics
BBlood sugar and weight2 topics
CCancer1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Blood pressure in adults | B | A 2024 meta-analysis of 22 RCTs found lower systolic (-7.87 mmHg) and diastolic (-3.23 mmHg) pressure, with very high heterogeneity (I² about 90%); authors called for higher-quality studies. [3] |
| Blood glucose and insulin | B | A 2024 meta-analysis of 32 RCTs found small reductions in fasting glucose (-2.22 mg/dL), fasting insulin, HbA1c (-0.22%) and HOMA-IR; authors called for longer trials. [4] |
| Blood glucose, insulin and HbA1c (2025 pooled analysis) | B | A 2025 meta-analysis of 34 RCTs (1,500 participants) found lower fasting glucose (-3.04 mg/dL), insulin and HOMA-IR, but no significant change in HbA1c; authors called for longer and larger trials. [9] |
| Blood lipids | C | A 2025 meta-analysis of 37 RCTs (2,695 participants) found HDL cholesterol rose 2.50 mg/dL, with no significant change in total or LDL cholesterol or triglycerides. [5] |
| PSA rise in men with prostate cancer | C | Data conflict on whether pomegranate juice slows PSA rise in men with high PSA; in advanced prostate cancer, adjunctive juice did not reduce PSA versus placebo. [2] |
Main constituents: Hydrolyzable tannins (punicalagins and punicalin) and tannin-based complex oligomers; ellagic acid [1]; Punicalagin, an ellagitannin, is the most abundant polyphenol; others include flavonols, anthocyanins and ellagic acid [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- A study gave 8 ounces of pomegranate juice daily to men for over 2 years without significant adverse effects. [2]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Nothing found
No published information found in the sources checked.
Details and sources - Pregnancy and breastfeedingDrinking pomegranate juice during pregnancy or while breastfeeding may be safe; little is known about other forms or plant parts.
1 statement in the profile.
Details and sources - Interactions with medicines4 listed
Statins; Warfarin; CYP3A and CYP2C9 substrates; Metformin
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications3 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographsNone found
No published information found in the sources checked.
Details and sources
- Pomegranate juice is believed to be safe and extract may also be safe; root, stem and peel may not be safe in large amounts because they contain harmful substances. [6]
- Side effects are uncommon; some people have digestive symptoms, and allergic reactions have been reported. [6]
- MSK warns that pomegranate juice may increase the risk of rhabdomyolysis in people taking statins, and that people with diabetes should note its sugar content. [2]
Interactions
| With | What happens |
|---|---|
| Statins | Pomegranate juice may increase the risk of rhabdomyolysis in patients on statin therapy. [2] |
| Warfarin | A case report suggests pomegranate juice may interact with warfarin. [2] |
| Drugs metabolized by CYP3A or CYP2C9 | Rat studies suggested inhibition, but human studies did not show clinically relevant effects on CYP3A or CYP2C9. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Of 27 pomegranate extract supplements tested by HPLC, only 5 had the typical pomegranate tannin profile; 17 were mainly ellagic acid and 5 had no detectable tannins or ellagic acid. Standardizing to ellagic acid does not guarantee authenticity. [1]
Regulatory status
- US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [7]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 3 entries naming pomegranate (Punica granatum) (earliest NDI 394 submitted 2006-04-24; most recent NDI 434 submitted 2006-12-15). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. All three describe a pomegranate fruit polyphenol extract. [P3]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- No published information found in the sources checked.
Interactions with medicines
- Statins: Juice may increase the risk of rhabdomyolysis. [P6]
- Warfarin: Case report of a possible interaction with pomegranate juice. [P6]
- CYP3A and CYP2C9 substrates: Inhibition in rats; human studies showed no clinically relevant inhibition. [P6]
- Metformin: In a rat model, pre-administered juice reduced metformin efficacy; human relevance not determined. [P6]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- Zhang et al. 2009: of 27 pomegranate extract supplements, 5 had the typical tannin profile, 17 contained mainly ellagic acid with minor or no pomegranate tannins, and 5 had no detectable tannins or ellagic acid; ellagic acid from cheaper plant sources can be used. [P1]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P7]
- HPLC profile of punicalagins, punicalin and ellagic acid (not ellagic acid alone) — Ellagic-acid standardization does not guarantee authenticity; most tested supplements lacked the pomegranate tannin profile. [P1]
Supply and conservation
- IUCN Red List: Least Concern (LC), via GBIF species API, retrieved 2026-10-29 (record for Punica granatum L.). [P8]
Absorption in people
- In one subject who drank 180 ml juice (25 mg ellagic acid, 318 mg punicalagins), plasma ellagic acid peaked at 31.9 ng/ml after 1 h and was eliminated by 4 h. [P2]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- No published information found in the sources checked.
Pregnancy and breastfeeding
- Drinking pomegranate juice during pregnancy or while breastfeeding may be safe; little is known about other forms or plant parts. [P9]
Sources for this profile
- Zhang Y, et al. Absence of pomegranate ellagitannins in the majority of commercial pomegranate extracts: implications for standardization and quality control. J Agric Food Chem 2009;57(16):7395-400 (PMID 20349921), 2009-08-26. pubmed.ncbi.nlm.nih.gov
- Seeram NP, et al. Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 2004;348(1-2):63-8 (PMID 15369737), 2004-10. pubmed.ncbi.nlm.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Pomegranate (last updated November 11, 2022), 2022-11-11. mskcc.org
- eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Punica granatum L., 2026-10-29. api.gbif.org
- NCCIH. Pomegranate (Herbs at a Glance; last updated April 2025), 2025-04. nccih.nih.gov
Sources
- Zhang Y, et al. Absence of pomegranate ellagitannins in the majority of commercial pomegranate extracts: implications for standardization and quality control. J Agric Food Chem 2009;57(16):7395-400 (PMID 20349921), 2009-08-26. pubmed.ncbi.nlm.nih.gov
- Memorial Sloan Kettering Cancer Center. About Herbs: Pomegranate (last updated November 11, 2022), 2022-11-11. mskcc.org
- Bahari H, et al. The effects of pomegranate consumption on blood pressure in adults: a systematic review and meta-analysis. Phytother Res 2024;38(5):2234-2248 (PMID 38410857), 2024-05. pubmed.ncbi.nlm.nih.gov
- Bahari H, et al. The effects of pomegranate consumption on glycemic indices in adults: a systematic review and meta-analysis. Diabetes Metab Syndr 2024;18(1):102940 (PMID 38194826), 2024-01. pubmed.ncbi.nlm.nih.gov
- Cheng W, et al. An updated systematic review and meta-analysis of pomegranate consumption on lipid profile. Prostaglandins Other Lipid Mediat 2025;178:106992 (PMID 40216355), 2025-06. pubmed.ncbi.nlm.nih.gov
- NCCIH. Pomegranate (Herbs at a Glance; last updated April 2025), 2025-04. nccih.nih.gov
- U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
- Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Punica granatum L.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
- Mohammadzaheri F, et al. The effect of pomegranate products on glycemic profile in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials. BMC Nutr 2025;11(1):168 (PMID 40847381), 2025-08-22. pubmed.ncbi.nlm.nih.gov
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.